Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
May 04, 2023 16:05 ET
|
Relay Therapeutics, Inc.
Presented initial clinical data for RLY-2608 at American Association for Cancer Research (AACR) Annual Meeting 2023 Initiated clinical trial for RLY-5836, a chemically-distinct PI3Kα pan-mutant...